CMR Surgical Secures $68.75 Million Growth Capital from Trinity Capital
Deal News | Apr 02, 2025 | Trinity Capital
Trinity Capital Inc., a prominent alternative asset management firm, has announced its commitment to providing up to $68.75 million in growth capital to CMR Surgical, a global medical device enterprise focused on advancing robotic surgery through its Versius Surgical Robotic System. This substantial investment is part of CMR's broader financing round exceeding $200 million. Based in Cambridge, UK, CMR Surgical recently received FDA approval to market its Versius system for cholecystectomy procedures in the U.S. The funding will enable the company to scale operations and expand the reach of Versius across more medical facilities worldwide, with a strategic emphasis on the U.S. market. Rob Lake, a senior director at Trinity Capital, and Massimiliano Colella, CEO of CMR Surgical, both expressed optimism about the firm's innovative potential and market readiness. Founded in 2014, CMR aims to make robotic-assisted surgeries more universally accessible with the help of strategic financial partners like Trinity Capital.
Sectors
- Medical Devices
- Private Equity
Geography
- United States – CMR Surgical has received FDA approval to market their Versius system in the US, marking a significant geographical focus for expansion.
- United Kingdom – CMR Surgical is headquartered in Cambridge, UK, and plays an important role in the company’s operational strategy and development.
- International – Trinity Capital and CMR Surgical both operate internationally, with a widespread presence in various global markets.
Industry
- Medical Devices – CMR Surgical operates in the medical devices industry, focusing on robotic surgical systems aimed at improving surgical care and accessibility.
- Private Equity – Trinity Capital is involved in the private equity industry, providing growth capital to promising companies like CMR Surgical.
Financials
- 68.75 Million – Growth capital investment from Trinity Capital to CMR Surgical.
- 200 Million – Part of the overall financing round that CMR Surgical has recently completed.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Trinity Capital Inc. | Investor | Company | An alternative asset manager providing growth capital through private credit. |
| CMR Surgical | Target Company | Company | A medical devices company developing the Versius Surgical Robotic System for improved surgical access. |
| Rob Lake | Senior Managing Director, Life Sciences | Person | Representative of Trinity Capital commenting on the investment strategy. |
| Massimiliano Colella | Chief Executive Officer | Person | CEO of CMR Surgical responsible for steering company strategy and growth. |